Pepvise
REVIEW DATABASE · 9 entries

Peptide reviews on one yardstick.

Every compound scored on the same five dimensions — published evidence, mechanism plausibility, human data, vendor trust, regulatory posture — and ranked. Last database refresh 2026-04-29.

Last refreshed
Methodology v1.2
Buying guides · Consumer peptides

The peptides you can actually buy, ranked.

Collagen peptide powders and peptide skincare, held to the same evidence yardstick as the research compounds. Rankings set by the ingredient panel and the published trials; commissions never reorder a list.

Start with the evidence: Collagen peptides, the evidence · Peptides in skincare · Copper peptides (GHK-Cu)

THE TOP RANKED

The research-peptide literature, ranked.

Nine compounds in active rotation, scored on a 10-point composite. Updated quarterly.

1
LEAD REVIEW
BPC-157
Body Protection Compound 157
The most-studied research peptide in rodents. Human evidence remains thin and the FDA narrowed its compounding pathway in 2023.
7.8
7.0
6.8/10
Read review
2
MOST REQUESTED
TB-500
Thymosin Beta-4 fragment
The actin-binding biology is real; what most online sources sell as TB-500 is a fragment, not the full thymosin beta-4 protein.
6.4
6.5
5.9/10
Read review
3
HIGHEST SCORE
GHK-Cu
Copper tripeptide
The cleanest evidence file in the database, peer-reviewed cosmetic and wound work, plus topical formulations available outside the research channel.
8.6
8.4
8.1/10
Read review
4
ALSO REVIEWED
MOTS-c
Mitochondrial Open-Reading-Frame of the 12S rRNA-c
Mitochondrial-derived 16-aa peptide with a coherent metabolic-signalling mechanism. Human evidence remains limited to small early-phase pilots.
6.5
6.0
5.9/10
Read review
5
ALSO REVIEWED
AOD-9604
Anti-Obesity Drug 9604, growth hormone fragment 176-191
Synthetic 16-amino-acid fragment of human growth hormone. Failed Phase 2b for obesity (2007). Marketed as a research peptide despite the negative trial outcome.
5.0
6.5
5.1/10
Read review
6
ALSO REVIEWED
CJC-1295
GRF(1-29) analogue with DAC modification
Long-acting GHRH analogue. Strong mechanism, defined PK profile, very limited published human evidence beyond Phase 1.
5.5
5.5
5.2/10
Read review
7
ALSO REVIEWED
Ipamorelin
GHRP-class growth-hormone secretagogue
Selective ghrelin receptor agonist with cleaner GH-release profile than older GHRPs. Phase 2 in postoperative ileus failed; remains a research-channel-only peptide.
5.5
6.0
5.2/10
Read review
8
RUNNER-UP
Tesamorelin
synthetic GHRH analogue (Egrifta)
FDA-approved GHRH analogue for HIV-associated lipodystrophy. The most-developed peptide in the GHRH/GHRP class with a regulated indication.
8.0
7.5
7.7/10
Read review
9
ALSO REVIEWED
Sermorelin
GHRH(1-29), formerly Geref
29-amino-acid GHRH fragment; previously FDA-approved for paediatric GH deficiency (Geref, withdrawn 2008). Now a compounding-pharmacy product without a current FDA-approved label.
5.5
6.5
6.0/10
Read review
SIDE BY SIDE

Top four on every dimension.

Higher is better. Numbers are tabular, the methodology is on the methodology page, and yes — vendor trust counts because counterfeit risk is real.

#COMPOUNDEVIDENCEMECHANISMHUMAN DATAVENDOR TRUSTSAFETYTOTAL
1BPC-157
Body Protection Compound 157
7.88.24.06.57.06.8
2TB-500
Thymosin Beta-4 fragment
6.47.53.25.86.55.9
3GHK-Cu
Copper tripeptide
8.68.56.88.28.48.1
4MOTS-c
Mitochondrial Open-Reading-Frame of the 12S rRNA-c
6.57.83.55.56.05.9
Latest from the journal

New reviews and evidence files.

Every post is graded against the published literature and dated, and we revise with a note when the file changes.

Consumer

Argireline, examined

Acetyl hexapeptide-8 is sold as a needle-free Botox alternative. The one study behind the claim, what concentration actually matters, and where it fits next to peptides with better evidence.

Jun 4, 20268 min read
Regulation

Peptide therapy, separated from the marketing

Wellness clinics offer peptide therapy for recovery, anti-aging and fat loss. What the term actually covers, which peptides are FDA-approved for what, and the regulatory grey zone most of it lives in.

Jun 4, 202611 min read
Evidence

Peptides for muscle growth, honestly graded

Growth-hormone secretagogues, IGF-1 peptides and collagen all get sold for muscle. What the human trials actually show, why GH peptides disappoint lifters, and the legal options that beat all of them.

Jun 4, 202611 min read
Evidence

Peptides for weight loss, graded by evidence

One peptide class genuinely drives weight loss in trials. The rest, sold as fat-loss peptides in the research-chemical channel, range from weakly supported to abandoned. An honest map of both.

Jun 4, 202612 min read
Consumer

Matrixyl, decoded

Matrixyl, Matrixyl 3000 and Matrixyl synthe'6 are three different peptide technologies wearing one trade name. Which is which on an ingredient list, what the published evidence supports, and which products carry a real dose.

Jun 4, 20269 min read
Consumer

Marine collagen, examined

Fish-skin collagen is pitched as better absorbed, better for skin, and more sustainable. One of those claims holds up under the literature. The chemistry, the trials, and who should actually choose marine.

Jun 4, 20269 min read
BROWSE BY CATEGORY

Five shelves. Every review fits one.

Each shelf carries the reviews and the comparison tables for a single research domain.

HOW WE SCORE

Five dimensions, weighted, on every review.

Every score on Pepvise breaks down into the same five components. Read the full methodology if you want to argue with the weights — we will hear you out.

Read the full methodology
Methodology v1.2
01
Published evidence

Sample size, replication count, and study design across PubMed, ClinicalTrials.gov, and FDA filings. Mouse-only literature gets capped.

25%
02
Mechanism plausibility

Whether the proposed mechanism is consistent with established cell biology, or whether it is back-fitted to the marketing claim.

15%
03
Human data

Trial phase, sample size, follow-up length, and the gap between rodent dose and the human dose actually studied.

25%
04
Vendor trust

Counterfeit incidence, third-party assay availability, regulatory posture of typical sources. Not an endorsement of any vendor.

15%
05
Regulatory posture

FDA approval status, 503A/503B compoundability, WADA status, and the realistic legal pathway for a US patient or athlete.

20%
WHAT IS NEXT

On the pipeline.

Twelve reviews live, eight more in active drafting. Here is what is coming and when.

CompoundStageEditorTarget pub
EpithalonEpitalonDraftingM. Otieno2026-06-12
Thymosin α1Editor reviewS. Han2026-06-19
SelankPre-publication holdM. Otieno2026-07-03
SemaxPre-publication holdM. Otieno2026-07-10
See the full pipeline
THE DISPATCH

One review a week. No vendor links. Ever.

When a new compound enters the database — or when an existing review gets a score change — subscribers hear about it first.

By subscribing you accept the privacy policy. One-click unsubscribe.